Covered recipient · General Payments record
REBA S WEYMOUTH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,259.25
- Reported across 137 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $718.48 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $425.42 | 23 |
| Galderma Laboratories, L.P. | $249.81 | 6 |
| Novo Nordisk AS | $43.25 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.63 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400109 | CMS |
| ABBVIE INC. | $8.39 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400111 | CMS |
| ABBVIE INC. | $6.64 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400113 | CMS |
| ABBVIE INC. | $8.55 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400115 | CMS |
| ABBVIE INC. | $34.33 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400117 | CMS |
| ABBVIE INC. | $6.15 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400119 | CMS |
| ABBVIE INC. | $0.78 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400121 | CMS |
| ABBVIE INC. | $21.91 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400123 | CMS |
| ABBVIE INC. | $20.00 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400125 | CMS |
| ABBVIE INC. | $1.83 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400127 | CMS |
| ABBVIE INC. | $25.50 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400129 | CMS |
| ABBVIE INC. | $3.88 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400131 | CMS |
| ABBVIE INC. | $8.30 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400133 | CMS |
| ABBVIE INC. | $4.18 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400135 | CMS |
| ABBVIE INC. | $13.97 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400137 | CMS |
| ABBVIE INC. | $24.34 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400139 | CMS |
| ABBVIE INC. | $7.12 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400141 | CMS |
| ABBVIE INC. | $20.21 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400143 | CMS |
| ABBVIE INC. | $115.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400145 | CMS |
| ABBVIE INC. | $18.09 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400147 | CMS |
| ABBVIE INC. | $2.04 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400149 | CMS |
| ABBVIE INC. | $14.28 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400151 | CMS |
| ABBVIE INC. | $31.30 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108400153 | CMS |
| Galderma Laboratories, L.P. | $8.90 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145400441 | CMS |
| Galderma Laboratories, L.P. | $102.77 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145400443 | CMS |
| Galderma Laboratories, L.P. | $12.90 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145400445 | CMS |
| Galderma Laboratories, L.P. | $15.40 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145400447 | CMS |
| Galderma Laboratories, L.P. | $26.92 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145400449 | CMS |
| Galderma Laboratories, L.P. | $82.92 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145400451 | CMS |
| Novo Nordisk Inc | $21.79 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100463912 | CMS |
| Novo Nordisk Inc | $21.46 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100260161 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.